uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
IXinity
Application withdrawn
Human
Details
EMA number
EMEA/H/C/002349
ATC code
B02BD12
Authorisation
-
Revision
-
EMA page
Therapeutic indication
treatment of hemophilia B
MeSH:
Hemophilia B
Active substances
trenonacog alfa
Marketing Authorisation Holder
Cangene Europe Limited
MAH
IXinity | uMedical